CTI Honored with 2018 Business Impact Award

CTI was named the winner of the Vision Award category, which was awarded to the organization for inspiring and delivering new thinking to the marketplace and for showcasing Northern Kentucky as an area of thoughtful, innovative industry leaders.

"We're honored to be recognized by the Northern Kentucky Chamber of Commerce with this award for CTI's continued successes and innovations," according to Timothy J. Schroeder, Founder and CEO. 

CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experience, and strong local expertise in Europe and Latin America.

Bexion and CTI Announce Completion of First-in-Human Trial Using BXQ-350 for the Treatment of Cancer

“CTI is extremely happy to partner with Bexion on the development of this novel therapy in patients who desperately need alternative treatments,” stated William Aronstein, PhD, MD, FACP, Vice President, Medical Affairs at CTI. “They are an innovative organization with very strong regional ties – the drug was initially developed and licensed at a local hospital, early funding has predominantly come from the region, and the management and board have strong local connections.”

CTI Announces Continued Growth Across Europe and Asia

“The expansions in Taiwan and Japan are part of continued efforts to increase capacity for clinical research across Asia,” according to Patrick Earley, Vice President, International. “We have been working across Asia for a number of years, but felt like a more permanent presence in Taipei and Tokyo would further enhance relationships with local medical centers and biotechnology companies."

 

Regenerative Medicine / Gene Therapy

Find out how CTI can provide value to regenerative medicine and gene therapy programs as a leader in the field.

Learn More

Phase I Studies

The CTI CRC Phase I unit is a state-of-the-art facility designed specifically to conduct early phase clinical pharmacology trials.

Learn More

Participate in a Trial

Icon Careers Small Retina

CTI CRC is looking for volunteers to participate in our current trials. 

Learn More

Join our Team

Icon Briefcase Small Retina

CTI is always looking for talented individuals to join our team around the world!

Learn More